SCHEMBL23555769

SCHEMBL23555769

Cc1nc2nc(Cl)c(Br)cc2c(=O)n1Cc1ccc(Cl)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.55
▸ ALDH1A1 P00352 6/20 0.55
▸ SMN1; SMN2 Q16637 4/20 0.55
▸ HSD17B10 Q99714 3/20 0.55
▸ HPGD P15428 1/20 0.55
▸ MEN1 O00255 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ LMNA P02545 3/20 0.49
▸ HDAC3 O15379 1/20 0.49
▸ HDAC4 P56524 1/20 0.49
▸ HDAC1 Q13547 1/20 0.49
▸ HDAC7 Q8WUI4 1/20 0.49
▸ HDAC2 Q92769 1/20 0.49
▸ HDAC10 Q969S8 1/20 0.49
▸ HDAC11 Q96DB2 1/20 0.49
▸ HDAC8 Q9BY41 1/20 0.49
▸ HDAC6 Q9UBN7 1/20 0.49
▸ HDAC9 Q9UKV0 1/20 0.49
▸ HDAC5 Q9UQL6 1/20 0.49
▸ NPC1 O15118 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23555767 0.85 ALDH1A1 (0.55) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD
SCHEMBL23555765 0.83 ALDH1A1 (0.53) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD
SCHEMBL23555763 0.81 ALDH1A1 (0.54) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD
SCHEMBL23555558 0.76 TP53 (0.62) MEN1KMT2ALMNAHDAC6MAPK1
SCHEMBL23555541 0.76 ALDH1A1 (0.62) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD
SCHEMBL23555535 0.74 ALDH1A1 (0.60) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD
SCHEMBL15215746 0.72 ALDH1A1 (0.56) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD
SCHEMBL23555766 0.71 KDM4E (0.51) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD
SCHEMBL3330739 0.69 KDM4E (0.45) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD
SCHEMBL31196722 0.69 SMN1; SMN2 (0.70) KDM4EALDH1A1SMN1; SMN2HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127071-A1 BICYCLIC HETEROCYCLE COMPOUNDS METHODS OF USE THEREOF FOR THE TREATMENT OF HERPES VIRUSES MERCK SHARP & DOHME CORP. (US) 2021-06-24 — — WO disclosed
Send feedback